Phenobarbital Sodium is a Intramuscular; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Nivagen Pharmaceuticals, Inc.. The primary component is Phenobarbital Sodium.
| Product ID | 75834-288_97652610-107d-48d1-ba21-51586f50b55f |
| NDC | 75834-288 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Phenobarbital Sodium |
| Generic Name | Phenobarbital Sodium |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2021-09-15 |
| Marketing Category | UNAPPROVED DRUG OTHER / |
| Labeler Name | Nivagen Pharmaceuticals, Inc. |
| Substance Name | PHENOBARBITAL SODIUM |
| Active Ingredient Strength | 65 mg/mL |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-09-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0641-0476 | Phenobarbital Sodium | Phenobarbital Sodium |
| 0641-0477 | Phenobarbital Sodium | Phenobarbital Sodium |
| 14789-127 | Phenobarbital Sodium | Phenobarbital Sodium |
| 14789-128 | Phenobarbital Sodium | Phenobarbital Sodium |
| 42494-415 | Phenobarbital Sodium | Phenobarbital Sodium |
| 42494-416 | Phenobarbital Sodium | Phenobarbital Sodium |
| 54288-136 | Phenobarbital Sodium | Phenobarbital Sodium |
| 54288-137 | Phenobarbital Sodium | Phenobarbital Sodium |
| 63629-1997 | Phenobarbital Sodium | Phenobarbital Sodium |
| 63629-1998 | Phenobarbital Sodium | Phenobarbital Sodium |
| 63629-2007 | Phenobarbital Sodium | Phenobarbital Sodium |
| 63629-2008 | Phenobarbital Sodium | Phenobarbital Sodium |
| 75834-288 | Phenobarbital Sodium | Phenobarbital Sodium |
| 75834-289 | Phenobarbital Sodium | Phenobarbital Sodium |
| 62756-301 | SEZABY | phenobarbital sodium |